The content on this site is intended for healthcare professionals only
Prof Giagounidis (St. John’s Hospital, Duisburg, Germany) chairs a discussion with Dr Zaja (University of Udine, Udine, Italy), Dr Liebman (University of Southern California, Los Angeles, USA), and Dr Bussel (Cornell University, Ithaca, USA) for ecancertv at EHA 2014 about the latest in ITP treatment options.
In particular, they discuss the latest clinical evidence and best treatment practice in chronic adult ITP, present the latest long-term data for TPO-R agonists with a focus on eltrombopag, and give expert insight into the management of challenging cases of chronic adult ITP.
Read the prescribing information here.
Content taken from a GlaxoSmithKline sponsored satellite symposium at EHA 2014 as part of the official programme.
Date of preparation: July 2014, OF/ELT/0079/14a
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Relapsed refractory multiple myeloma
Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer
CAR-T therapy and impact to cancer patient outcomes and experience of treatment
